Acumen Pharmaceuticals (ABOS) Change in Account Payables (2020 - 2026)
Acumen Pharmaceuticals (ABOS) reported Change in Account Payables of $1.0 million for Q1 2026, up 122.8% on a YoY basis from $469927.1 in Q1 2025, and up 917.97% sequentially from -$128000.0 in Q4 2025.
Acumen Pharmaceuticals (ABOS) Change in Account Payables (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 7 years of Change in Account Payables data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 122.8% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $545000.0 (up 126.94% YoY), and the FY2025 full-year result was -$5.1 million, down 219.33% from the prior year.
- Change in Account Payables improved to $1.0 million in Q1 2026, from -$128000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.3 million in Q4 2024 to a low of -$4.6 million in Q1 2025.
- A 5-year average of $30176.5 and a median of $121000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables tumbled 825.62% in 2023 and jumped 19347.06% in 2024, its largest moves.
- Tracing ABOS's Change in Account Payables over 5 years: stood at -$444000.0 in 2022, then jumped by 103.83% to $17000.0 in 2023, then jumped by 19347.06% to $3.3 million in 2024, then tumbled by 103.87% to -$128000.0 in 2025, then jumped by 917.97% to $1.0 million in 2026.
- Business Quant data shows ABOS's Change in Account Payables at $1.0 million in Q1 2026, -$128000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Acumen Pharmaceuticals | 140.98 Mn | 140.98 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | -128,000.00 |
| Dec 31, 2025 | -128,000.00 |
| Sep 30, 2025 | -1.42 Mn |
| Sep 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | -4.59 Mn |
| Mar 31, 2025 | -4.59 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |